SCHEMBL2449458

SCHEMBL2449458

Cc1ccc(C(=O)S([NH])(=O)=O)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.52
CES2 O00748 3/20 0.52
CES1 P23141 3/20 0.52
LMNA P02545 2/20 0.52
SMN1; SMN2 Q16637 3/20 0.50
KMT2A Q03164 4/20 0.46
TDP1 Q9NUW8 3/20 0.46
MEN1 O00255 3/20 0.46
PKM P14618 2/20 0.46
HTT P42858 2/20 0.46
ATM Q13315 2/20 0.46
NPSR1 Q6W5P4 2/20 0.46
GAA P10253 2/20 0.46
HPGD P15428 1/20 0.46
NLRP1 Q9C000 1/20 0.46
NTSR1 P30989 1/20 0.46
SRD5A2 P31213 1/20 0.45
HDAC1 Q13547 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
GSK3B P49841 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL180685 0.81 ALDH1A1 (0.56) ALDH1A1CES2CES1LMNASMN1; SMN2
SCHEMBL1148875 0.79 ALDH1A1 (0.54) ALDH1A1CES2CES1LMNASMN1; SMN2
SCHEMBL1412844 0.79 ALDH1A1 (0.54) ALDH1A1CES2CES1LMNASMN1; SMN2
SCHEMBL777939 0.79 ALDH1A1 (0.54) ALDH1A1CES2CES1LMNASMN1; SMN2
SCHEMBL2221935 0.77 ALDH1A1 (0.52) ALDH1A1CES2CES1LMNASMN1; SMN2
SCHEMBL2113832 0.77 ALDH1A1 (0.52) ALDH1A1CES2CES1LMNASMN1; SMN2
SCHEMBL4846247 0.76 CES1 (0.48) ALDH1A1CES2CES1LMNASMN1; SMN2
SCHEMBL27962643 0.76 ALDH1A1 (0.53) ALDH1A1CES2CES1LMNASMN1; SMN2
SCHEMBL777046 0.76 ALDH1A1 (0.50) ALDH1A1CES2CES1LMNASMN1; SMN2
SCHEMBL7670480 0.74 ALDH1A1 (0.48) ALDH1A1CES2CES1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 443 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6737429-B2 TREATMENT OF HIV MEDIATED DISEASES. HOFFMANN-LA ROCHE INC. 2004-05-18 US claimed
EP-1301481-A1 PYRROLE DERIVATIVES FOR TREATING AIDS F. HOFFMANN-LA ROCHE AG (CH) 2003-04-16 EP claimed
US-20020032221-A1 Pyrrole derivatives ROCHE PRODUCTS LIMITED (GB) 2002-03-14 US claimed
WO-2002002524-A1 PYRROLE DERIVATIVES FOR TREATING AIDS F. HOFFMANN-LA ROCHE AG (CH) 2002-01-10 WO claimed
EP-1980908-B1 Use of silver halide photographic material and image forming method FUJIFILM CORP (JP) 2011-09-07 EP disclosed
US-7592133-B2 Silver halide photographic material and image forming method using the same FUJIFILM CORPORATION (JP) 2009-09-22 US disclosed
US-7449500-B2 Ink jet ink containing multimetallic polymeric colorants EASTMAN KODAK COMPANY (US) 2008-11-11 US disclosed
US-7449287-B1 Pearlescent textured imaging supports EASTMAN KODAK COMPANY (US) 2008-11-11 US disclosed
US-20080268385-A1 Silver halide photographic material and image forming method using the same FUJIFILM CORPORATION (JP) 2008-10-30 US disclosed
EP-1980908-A1 Silver halide photographic material and image forming method using the same FUJIFILM Corporation (JP) 2008-10-15 EP disclosed
EP-0962499-B2 Direct preparation of pigmentary pyrrolo-(3,4-C)pyrroles CIBA SC HOLDING AG (CH) 2008-03-05 EP disclosed
EP-1740662-B1 INK JET INK SET EASTMAN KODAK CO (US) 2007-09-12 EP disclosed
EP-0094911-A2 Preparation of pyrrolo-(3,4-c) pyrroles CIBA-GEIGY AG (CH) 1983-11-23 EP disclosed
US-4415685-A POLYMERIC FLUORESCENT RED DYES; LACQUERS; TONERS; VARNISHES; FIBERS; PLASTICS; COLOR FASTNESS CIBA-GEIGY CORPORATION (US) 1983-11-15 US disclosed
EP-0061426-A1 Process for colouring highly molecular organic material and polycyclic pigments CIBA-GEIGY AG (CH) 1982-09-29 EP disclosed
US-4022799-A DYEING, PRINTING OF NATURAL AND SYNTHETIC MATERIALS BAYER AKTIENGESELLSCHAFT (DT) 1977-05-10 US disclosed
US-4001253-A NAPHTHOLACTAM DYESTUFFS BAYER AKTIENGESELLSCHAFT (DT) 1977-01-04 US disclosed
US-3966405-A N-Alkyl nitro phenyl diethylene triamine dyeing of acid modified synthetic fibers HOECHST AKTIENGESELLSCHAFT (DT) 1976-06-29 US disclosed
US-3963436-A Bis nitrophenyl diethylene triamine dyeing of synthetic acid modified fibers HOECHST AKTIENGESELLSCHAFT (DT) 1976-06-15 US disclosed
US-3950347-A NAPHTHOLACTAM DYESTUFFS BAYER AKTIENGESELLSCHAFT (DT) 1976-04-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020032221-A1 Pyrrole derivatives PYCR1, SARS1, MAVS ALDH1A1 2902/4885CES2 1902/4885CES1 3412/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.